Elseviers M.
74
Coauthors
7
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Farmacología | 3 |
| Cáncer | 3 |
| Salud pública | 3 |
| Medicamento | 1 |
| Medicina interna | 1 |
| Política pública | 1 |
| Política | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 4 |
| Medicina y salud | 4 |
| Problemas sociales y servicios a grupos | 4 |
| Producción | 3 |
| Enfermedades | 2 |
| Salud y seguridad personal | 1 |
| Funcionamiento de bibliotecas y archivos | 1 |
| Otros problemas y servicios sociales | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 7 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Carlos E. Durán | 6 |
| Christiaens T. | 6 |
| Vander Stichele R. | 4 |
| Urtasun M.A. | 3 |
| Cañás M. | 3 |
| Klamer T. | 2 |
| Azermai M. | 2 |
| Wauters M. | 2 |
| Rottey S. | 2 |
| Stichele R.V. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Sharp rise in the expenditures of targeted drugs in Ecuador: five-year (2010–2014) consumption of oncologic drugs in public and private hospitals
ArticleAbstract: Objective: In Ecuador, a new constitutional mandate (2008) allowed the government to implement freePalabras claves:Cáncer, drug utilization, ECUADOR, health expenditures, Latin America, molecular targeted therapy, oncologic drugsAutores:Carlos E. Durán, Christiaens T., Elseviers M., Rottey S., Vander Stichele R.Fuentes:scopusPolicies influencing access to new targeted oncologic drugs in Ecuadorian hospitals: an interrupted time series analysis
ArticleAbstract: Objective and methods: An interrupted time series analysis was performed to measure the impact of twPalabras claves:antineoplastic drugs, drug and therapeutic committees, drug policies, ECUADOR, interrupted time series analysis, molecular targeted therapyAutores:Carlos E. Durán, Christiaens T., Elseviers M., Patricia Granja, Rottey S., Vander Stichele R.Fuentes:scopusPotential negative impact of reputed regulators decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis
ArticleAbstract: Background Many new cancer drugs are being approved by reputed regulatory authorities without evidenPalabras claves:Autores:Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopusA Novel Scale Linking Potency and Dosage to Estimate Anticholinergic Exposure in Older Adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale
ArticleAbstract: Quantification of the anticholinergic exposure insufficiently or imprecisely incorporates dosage infPalabras claves:Autores:Azermai M., Carlos E. Durán, Christiaens T., Elseviers M., Klamer T., Vander Stichele R., Wauters M.Fuentes:scopusRegulatory reliance to approve new medicinal products in Latin American and Caribbean countries
ArticleAbstract: Objective. To describe the current status of regulatory reliance in Latin America and the CaribbeanPalabras claves:Caribbean Region, Drug approval, Government Agencies, Latin America, Pan american health organization, Pharmaceutical preparations, United States Food and Drug AdministrationAutores:Andia T., Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopus